Skip directly to site content Skip directly to page options Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
														Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)


Facebook
        Twitter
        LinkedIn
        Syndicate





VINYL ACETATE								Related Pages
										*OSHA comments from the January 19, 1989 Final Rule on Air Contaminants Project extracted from 54FR2332 et. seq. This rule was remanded by the U.S. Circuit Court of Appeals and the limits are not currently in force.*
**CAS:** 108-05-4; **Chemical Formula:** CH3COOCH = CH2
There was no previous OSHA limit for vinyl acetate. OSHA proposed establishing a 10-ppm TWA and a 20-ppm STEL for this substance, based on the ACGIH recommendation, and the final rule establishes these limits. Vinyl acetate is a volatile liquid that polymerizes in light to a colorless, transparent mass and usually contains an inhibitor, such as hydroquinone.
The basis for the proposed limits is an epidemiologic report by Deese and Joyner (1969/Ex. 1-412) describing 15 years of industrial experience with vinyl acetate production. These authors reported that vinyl acetate is not a significant irritant at exposure levels of 5 to 10 ppm but causes cough and hoarseness at around 22 ppm. They also found no evidence of adverse chronic effects resulting from exposure to 5 to 10 ppm, as determined from medical records and examinations. While conducting air sampling for the study, the primary author (Deese) experienced hoarseness at concentrations of 4.2 to 5.7 ppm, and eye irritation at 5.7 to 6.8 ppm. Three chemical operators and one technician did not report any subjective responses at these levels. The ACGIH (1986/Ex. 1-3, p. 621) also cited a personal communication from the Mellon Institute (1968) stating that vinyl acetate concentrations of less than 5 ppm are detectable by odor, although some individuals may detect the odor at concentrations of 0.5 ppm (Mellon Institute 1968, as cited by ACGIH 1986/Ex. 1-3, p. 621).
NIOSH (1978i, as cited in ACGIH 1986/Ex. 1-3, p. 621) reviewed these data and concluded that the recommended exposure limit be designed to protect even the most sensitive individuals from sensory irritant effects. Since the lowest level reported to cause upper respiratory tract irritation was 4.2 ppm (Deese and Joyner 1969/Ex. 1-412), NIOSH recommended that workplace exposures not exceed 4 ppm measured over a 15-minute period. In its prehearing submission (Ex. 8-47, Table N2), NIOSH continued to recommend its earlier limit.
The NIOSH REL of 4 ppm (ceiling) relies on a report concerning the experience of a single individual; in contrast, the limits being established today are based on a 15-year epidemiology study that suggests that a 10-ppm TWA and a 20-ppm STEL will provide protection against the risk of irritation associated with exposure to vinyl acetate at higher levels. OSHA considers the irritation caused by exposure to vinyl acetate a material impairment of health. Therefore, the Agency is promulgating this 8-hour TWA and STEL combination as the revised limits for vinyl acetate.
										
							
								Page last reviewed:  September 28, 2011						Content source:  	National Institute for Occupational Safety and Health NIOSH
1988 OSHA PEL Project Documentation
Index of Chemical Names
Index of CAS Numbers Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue